• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同亲脂性β受体阻滞剂(普萘洛尔、美托洛尔、索他洛尔、阿替洛尔)在大鼠单次及多次给药后血浆和组织中的时辰药代动力学。

Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.

作者信息

Lemmer B, Winkler H, Ohm T, Fink M

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1985 Jul;330(1):42-9. doi: 10.1007/BF00586708.

DOI:10.1007/BF00586708
PMID:2864639
Abstract

Comparative pharmacokinetic studies with the beta-receptor blocking drugs propranolol, metoprolol, sotalol and atenolol, differing greatly in lipophilicity, and their main route of elimination were performed in light-dark-synchronized rats after equimolar single (6 mumoles/kg) or multiple (6 X 6 mumoles/kg) drug application. Drug concentrations were determined in plasma and various target organs of the drugs, e.g. heart, muscle, lung and brain, after drug application in the light period (L) and dark period (D), respectively. After single drug administration pharmacokinetic parameters of all drugs depended on the L and D conditions. Elimination half-lives in plasma and organs were shorter during D than during L. No L-D-differences were found in initial drug concentrations of the hydrophilic drugs sotalol and atenolol. In contrast, C0-values of the lipophilic propranolol in highly perfused organs (muscle, lung, brain) and of metoprolol in muscle tissue were significantly higher in D than in L. No obvious temporal dependency was found in other pharmacokinetic parameters (AUC, plasma clearance, Vd beta) with the exception in Vd beta of propranolol. Due to the different physico-chemical properties of the compounds inter-drug-differences in pharmacokinetic parameters including drug accumulation into lung and brain tissue were observed. Multiple drug dosing abolished the circadian-phase-dependency in the elimination half-lives of the drugs due to an increase in D. Only for the highly lipophilic propranolol half-lives in highly perfused organs were still shorter in D than in L.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在明暗同步的大鼠中,对等摩尔单次(6微摩尔/千克)或多次(6×6微摩尔/千克)应用亲脂性差异很大的β受体阻滞剂普萘洛尔、美托洛尔、索他洛尔和阿替洛尔及其主要消除途径进行了比较药代动力学研究。分别在光照期(L)和黑暗期(D)给药后,测定血浆和药物的各种靶器官(如心脏、肌肉、肺和脑)中的药物浓度。单次给药后,所有药物的药代动力学参数均取决于L和D条件。血浆和器官中的消除半衰期在D期比在L期短。亲水性药物索他洛尔和阿替洛尔的初始药物浓度未发现L-D差异。相比之下,亲脂性普萘洛尔在高灌注器官(肌肉、肺、脑)中的C0值以及美托洛尔在肌肉组织中的C0值在D期明显高于L期。除普萘洛尔的Vdβ外,其他药代动力学参数(AUC、血浆清除率、Vdβ)未发现明显的时间依赖性。由于化合物的物理化学性质不同,观察到药代动力学参数包括药物在肺和脑组织中的蓄积存在药物间差异。多次给药消除了药物消除半衰期的昼夜相依赖性,因为D期有所增加。仅对于高度亲脂性的普萘洛尔,高灌注器官中的半衰期在D期仍比L期短。(摘要截断于250字)

相似文献

1
Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.不同亲脂性β受体阻滞剂(普萘洛尔、美托洛尔、索他洛尔、阿替洛尔)在大鼠单次及多次给药后血浆和组织中的时辰药代动力学。
Naunyn Schmiedebergs Arch Pharmacol. 1985 Jul;330(1):42-9. doi: 10.1007/BF00586708.
2
Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.口服普萘洛尔、美托洛尔、阿替洛尔和索他洛尔的单剂量动力学:与亲脂性的关系。
Arzneimittelforschung. 1985;35(10):1580-2.
3
Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.不同β受体阻断药物对大鼠运动活动影响的昼夜节律依赖性。药物亲脂性的重要性。
Arzneimittelforschung. 1987 Mar;37(3):321-5.
4
Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.硝苯地平对普萘洛尔、美托洛尔和阿替洛尔药代动力学及药效学影响的研究。
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):29S-35S. doi: 10.1111/j.1365-2125.1984.tb02425.x.
5
Stereospecific and circadian-phase-dependent kinetic behavior of d,l-, l-, and d-propranolol in plasma, heart, and brain of light--dark-synchronized rats.
J Cardiovasc Pharmacol. 1982 Jul-Aug;4(4):635-44. doi: 10.1097/00005344-198207000-00016.
6
Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.六种β-肾上腺素能阻滞剂的N-亚硝基衍生物的形成及其对大鼠和人肝细胞的遗传毒性作用。
Cancer Res. 1991 May 1;51(9):2273-9.
7
[Comparative pharmacokinetics of beta-blockers].[β受体阻滞剂的比较药代动力学]
Nouv Presse Med. 1978 Sep 20;7(31):2685-7.
8
Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.β-肾上腺素受体阻断药在甲状腺疾病中的临床药代动力学
Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001.
9
Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.一系列剂量的阿替洛尔、索他洛尔和美托洛尔在48小时内对运动性心动过速的影响。
Clin Pharmacol Ther. 1981 Mar;29(3):295-302. doi: 10.1038/clpt.1981.39.
10
Beta-blocker brain concentrations in man.人体中β受体阻滞剂的脑内浓度。
Eur J Clin Pharmacol. 1985;28 Suppl:21-3. doi: 10.1007/BF00543705.

引用本文的文献

1
Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance.在主动监测中,β受体阻滞剂阿替洛尔的使用与前列腺癌分级升级之间的关联。
BJUI Compass. 2024 Oct 9;5(11):1095-1100. doi: 10.1002/bco2.441. eCollection 2024 Nov.
2
Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes.卡维地洛和美托洛尔均可保护 2 型糖尿病患者的心肌功能。
Physiol Rep. 2020 Mar;8(5):e14394. doi: 10.14814/phy2.14394.
3
Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures.

本文引用的文献

1
Antagonism by chlorisondamine and propranolol, but not by atenolol, of the circadian phase-dependent phentolamine-induced changes in the cardiac noradrenaline turnover in the rat.氯异吲哚铵和普萘洛尔而非阿替洛尔对大鼠心脏去甲肾上腺素周转中昼夜节律相依赖性酚妥拉明诱导变化的拮抗作用。
Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):205-12. doi: 10.1007/BF00505735.
2
Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.肝血流量和酶活性在普萘洛尔和索他洛尔动力学中的作用。
Br J Clin Pharmacol. 1980 Apr;9(4):399-405. doi: 10.1111/j.1365-2125.1980.tb01068.x.
3
Circadian organization of thirteen liver and six brain enzymes of the mouse.
严重低血糖引起的猝死是由心律失常和癫痫发作共同介导的。
Am J Physiol Endocrinol Metab. 2018 Aug 1;315(2):E240-E249. doi: 10.1152/ajpendo.00442.2017. Epub 2018 Feb 27.
4
A Combination of G Protein-Coupled Receptor Modulators Protects Photoreceptors from Degeneration.联合使用 G 蛋白偶联受体调节剂可保护感光细胞免受变性损伤。
J Pharmacol Exp Ther. 2018 Feb;364(2):207-220. doi: 10.1124/jpet.117.245167. Epub 2017 Nov 21.
5
The use of α- or β-blockers to ameliorate the chronic stress of captivity in the house sparrow ().使用α-或β-阻滞剂来改善家麻雀圈养的慢性应激()。 (原文括号部分内容缺失,翻译仅针对现有完整部分)
Conserv Physiol. 2016 Oct 15;4(1):cow049. doi: 10.1093/conphys/cow049. eCollection 2016.
6
A Potential Link between the C5a Receptor 1 and the β1-Adrenoreceptor in the Mouse Heart.小鼠心脏中C5a受体1与β1 - 肾上腺素能受体之间的潜在联系
PLoS One. 2016 Jan 4;11(1):e0146022. doi: 10.1371/journal.pone.0146022. eCollection 2016.
7
Therapeutic applications of circadian rhythms for the cardiovascular system.昼夜节律在心血管系统中的治疗应用。
Front Pharmacol. 2015 Apr 17;6:77. doi: 10.3389/fphar.2015.00077. eCollection 2015.
8
The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.心得平给药时间对人体运动期间其药代动力学及血流动力学效应的影响。
Eur J Clin Pharmacol. 1993;44(2):171-6. doi: 10.1007/BF00315476.
9
Effects of salbutamol upon performance on an operant screen for antidepressants.沙丁胺醇对一种用于筛选抗抑郁药的操作性筛选试验表现的影响。
Psychopharmacology (Berl). 1993;113(1):1-10. doi: 10.1007/BF02244325.
10
Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.健康受试者口服普萘洛尔的药代动力学和心血管效应的昼夜变化。
Eur J Clin Pharmacol. 1988;33(6):619-24. doi: 10.1007/BF00542498.
小鼠13种肝脏酶和6种脑酶的昼夜节律组织
Am J Anat. 1981 Nov;162(3):183-99. doi: 10.1002/aja.1001620302.
4
High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.用于定量分析血浆和组织中芳氧丙醇胺类药物普萘洛尔、美托洛尔和阿替洛尔的高效液相色谱法。
J Chromatogr. 1982 Mar 12;228:223-34. doi: 10.1016/s0378-4347(00)80435-1.
5
From an autopsy or biopsy to the physiologist's chronopsy (from the 3rd Italian postgraduate chronobiology course).
Chronobiologia. 1981 Apr-Jun;8(2):145-64.
6
Differences in the content and turnover of noradrenaline in rat heart atria and ventricles and circadian-phase-dependency.大鼠心房和心室中去甲肾上腺素的含量及周转率差异与昼夜节律依赖性
Experientia. 1983 Sep 15;39(9):998-1000. doi: 10.1007/BF01989770.
7
Propranolol and renal hemodynamics at rest and during exercise.普萘洛尔与静息及运动时的肾血流动力学
Int J Clin Pharmacol Ther Toxicol. 1983 Dec;21(12):611-4.
8
Determination of the beta-adrenoceptor blocking drug sotalol in plasma and tissues of the rat by high-performance liquid chromatography with ultraviolet detection.
J Chromatogr. 1984 Jul 13;309(1):187-92. doi: 10.1016/0378-4347(84)80023-7.
9
Stereospecific and circadian-phase-dependent kinetic behavior of d,l-, l-, and d-propranolol in plasma, heart, and brain of light--dark-synchronized rats.
J Cardiovasc Pharmacol. 1982 Jul-Aug;4(4):635-44. doi: 10.1097/00005344-198207000-00016.
10
An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents.β-肾上腺素能受体阻滞剂的比较脂溶性研究。
J Pharm Pharmacol. 1981 Mar;33(3):172-3. doi: 10.1111/j.2042-7158.1981.tb13743.x.